Canada Multiomics Market Size & Outlook, 2023-2030

The multiomics market in Canada is expected to reach a projected revenue of US$ 279.0 million by 2030. A compound annual growth rate of 17.1% is expected of Canada multiomics market from 2024 to 2030.
Revenue, 2023 (US$M)
$92.5
Forecast, 2030 (US$M)
$279.0
CAGR, 2024 - 2030
17.1%
Report Coverage
Canada

Canada multiomics market highlights

  • The Canada multiomics market generated a revenue of USD 92.5 million in 2023 and is expected to reach USD 279.0 million by 2030.
  • The Canada market is expected to grow at a CAGR of 17.1% from 2024 to 2030.
  • In terms of segment, product was the largest revenue generating product & service in 2023.
  • Services is the most lucrative product & service segment registering the fastest growth during the forecast period.


Multiomics market data book summary

Market revenue in 2023USD 92.5 million
Market revenue in 2030USD 279.0 million
Growth rate17.1% (CAGR from 2023 to 2030)
Largest segmentProduct
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationServices, Product
Key market players worldwideThermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group


Other key industry trends

  • In terms of revenue, Canada accounted for 3.9% of the global multiomics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. multiomics market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 279.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Multiomics Market Companies

Name Profile # Employees HQ Website

Canada multiomics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.


Product was the largest segment with a revenue share of 60.43% in 2023. Horizon Databook has segmented the Canada multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.


The country’s strong healthcare system, ample natural resources, and diverse ecosystems have positioned the country as a leader in multiomics technology. Moreover, the increase in R&D in biotechnology due to growing funding by government organizations has led to increased demand for genomics, thus boosting the market share.

In 2018, Genome Canada, a nonprofit organization funded by the Canadian government, announced its collaboration with various Canadian provinces and organizations to invest a total of USD 204.4 million in two initiatives related to the advancement of genomic technology and precision medicine. 

Moreover, in March 2022, the Canadian government allocated USD 13.8 million in federal funding to facilitate the advancement of genomics through 10 subsequent R&D initiatives. Thus, government initiatives and funding support for genomics research have contributed to the expansion of this market.

Reasons to subscribe to Canada multiomics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada multiomics market databook

  • Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada multiomics market , including forecasts for subscribers. This country databook contains high-level insights into Canada multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada multiomics market size, by product & service, 2018-2030 (US$M)

Canada Multiomics Market Outlook Share, 2023 & 2030 (US$M)

Canada multiomics market size, by product & service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more